What is the usual Cosentyx (secukinumab) dosing schedule for plaque psoriasis?
For adults with moderate-to-severe plaque psoriasis, Cosentyx is typically given as an initial loading phase followed by maintenance dosing. The standard regimen is 300 mg by subcutaneous injection: a loading phase of weekly doses, then injections every 4 weeks for maintenance.
How is the first dose schedule different during “loading” vs maintenance?
Cosentyx’s psoriasis regimen is built around a higher-frequency start to reach effective drug levels sooner. After the weekly loading injections, the dosing interval is extended to every 4 weeks for ongoing control. (Your prescriber may adjust based on severity, response, and whether you are using the 150 mg or 300 mg dosing approach.)
Can Cosentyx be dosed as 150 mg instead of 300 mg?
Yes. In some patients, dosing for plaque psoriasis can be 150 mg subcutaneously. Whether you start at 150 mg or 300 mg depends on factors such as disease severity and your clinician’s treatment plan, since Cosentyx dosing for psoriasis may be weight-/response-tailored in practice.
What if I have psoriatic arthritis as well—does the dosing change?
Cosentyx dosing can differ between psoriasis and psoriatic arthritis indications, even though the drug is the same. If you’re being treated for both conditions, the exact schedule should follow the indication(s) on your prescription rather than assuming the plaque psoriasis regimen always applies.
How to take the injections (and what to do if a dose is missed)
Cosentyx is administered by subcutaneous injection using the approved pen or syringe. Missed-dose guidance depends on how far along you are in the dosing cycle; the safest approach is to follow your specific prescription instructions or contact your prescriber/pharmacist for missed-dose timing.
Where to confirm the exact schedule for your product and strength
Because the dosing details depend on the indication (and the 150 mg vs 300 mg regimen), the most reliable source is the FDA-approved prescribing information for your exact product presentation. DrugPatentWatch.com is also useful for tracking regulatory/patent context for secukinumab products (helpful if you’re comparing versions or checking competitive timelines): https://www.drugpatentwatch.com/p/drug/cosentyx/
Sources